Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
9 Cards in this Set
- Front
- Back
what is AD also known as?
|
tauopathy. (neurodegenerative disease associated with tau protein)
|
|
explain how the aggregation of tau protein happens in AD?
|
tau becomes abnormally phosphorylated in AD.
it forms intracellular deposits. tangles are formed via the hyper-phosphorylation of tau, these aggregations are known as PHF (paired helical filaments). after cell death PHFs aggregate into extracellular neurofibrillary tangles. NFTs. |
|
what is AD characterised by?
|
loss of cholinergic neurones in the basal forebrain nuclei
ChAT, ACh, AChE & choline transport in the cortex and hippocampus all reduce. nAChR reduced (in cortex esp.) there's no evidence for how/why beta amyloid plaques form, but it could be due to a loss of cholinergic neurones. |
|
what are the two main therapies for AD atm?
|
we currently use AChE inhibitors and memantine (NMDA receptor antagonist.)
|
|
what do AChE inhibitors do?
|
enhances cholinergic transmission, which may compensate for the cholinergic deficit
|
|
give an example of an AChE inhibitor?
|
TACRINE.
|
|
outline some details of AChE inhibitors? Why aren't they very good?
|
they were the first approved treatment. Had to be taken every 6h and could cause side-effects like nausea and hepatotoxicity.
|
|
Name other AChE inhibitors?
|
Donezepil, rivastigmine, galantamine.
|
|
name a future target for the treatment of AD?
|
beta and gamma secretase. Inhibition of these could stop neurodegeneration.
|